Cargando…
The role of polysaccharide peptide of Ganoderma lucidum as a potent antioxidant against atherosclerosis in high risk and stable angina patients
OBJECTIVES: Antioxidants can reduce oxidative radicals that affect the early phase of atherogenesis, that is endothelial dysfunction. Polysaccharide Peptide (PsP) derived from Ganoderma lucidum has an active substance in the form of β-glucan. Previous studies have proven the PsP of Ganoderma lucidum...
Autores principales: | Sargowo, Djanggan, Ovianti, Nadia, Susilowati, Eliana, Ubaidillah, Nizamuddin, Widya Nugraha, Adriyawan, Vitriyaturrida, Siwi Proboretno, Kartika, Failasufi, Mirza, Ramadhan, Fadhli, Wulandari, Hesti, Waranugraha, Yoga, Hayuning Putri, Dinarsari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204443/ https://www.ncbi.nlm.nih.gov/pubmed/30392496 http://dx.doi.org/10.1016/j.ihj.2017.12.007 |
Ejemplares similares
-
Oral Presentation Award Winner: Polysaccharide Peptide of Ganoderma lucidum Reduces Endothelial Injury in Stable Angina and High-risk Patients
por: Susilowati, Eliana, et al.
Publicado: (2021) -
Polysaccharide peptide (PsP) Ganoderma lucidum: a potential inducer for vascular repair in type 2 diabetes mellitus model
por: Heriansyah, Teuku, et al.
Publicado: (2019) -
The reduction of aorta histopathological images through inhibition of reactive oxygen species formation in hypercholesterolemia rattus norvegicus treated with polysaccharide peptide of Ganoderma lucidum
por: Andri Wihastuti, Titin, et al.
Publicado: (2015) -
Intermittent Pacemaker Malfunction Caused by Continuous Compression of the Lead by the Clavicle (Subclavian Crush Syndrome)
por: Rizal, Ardian, et al.
Publicado: (2020) -
The role of methylenetetrahydrofolate reductase C677T gene polymorphism as a risk factor for coronary artery disease: a cross-sectional study in the Sidoarjo Regional General Hospital
por: Sugijo, Hairudi, et al.
Publicado: (2022)